<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0030">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Solaimanzadeh</surname>
    <given-names>I.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Acetazolamide, nifedipine and phosphodiesterase inhibitors: Rationale for their utilization as adjunctive countermeasures in the treatment of Coronavirus Disease 2019 (COVID-19)</article-title>. 
  <source>
   <italic toggle="yes">Cureus</italic>
  </source>, (
  <issue>3</issue>), 
  <fpage>e7343</fpage>
  <pub-id pub-id-type="doi">10.7759/cureus.7343</pub-id>
  <pub-id pub-id-type="pmid">32226695</pub-id>
 </mixed-citation>
</ref>
